160 related articles for article (PubMed ID: 16083440)
21. Role of C3a and C5a in the activation of mast cells.
Erdei A; Kerekes K; Pecht I
Exp Clin Immunogenet; 1997; 14(1):16-8. PubMed ID: 9187918
[TBL] [Abstract][Full Text] [Related]
22. Fc (IgG) receptors on rat basophilic leukemia cells.
Segal DM; Sharrow SO; Jones JF; Siraganian RP
J Immunol; 1981 Jan; 126(1):138-45. PubMed ID: 6161157
[TBL] [Abstract][Full Text] [Related]
23. Affinity improvement of the high-affinity immunoglobulin E receptor by phage display.
Iwasaki A; Doi T; Umetani M; Watanabe M; Suda M; Hattori Y; Nagoya T
Biochem Biophys Res Commun; 2002 Apr; 293(1):542-8. PubMed ID: 12054635
[TBL] [Abstract][Full Text] [Related]
24. Label-free, real-time monitoring of IgE-mediated mast cell activation on microelectronic cell sensor arrays.
Abassi YA; Jackson JA; Zhu J; O'Connell J; Wang X; Xu X
J Immunol Methods; 2004 Sep; 292(1-2):195-205. PubMed ID: 15350524
[TBL] [Abstract][Full Text] [Related]
25. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Exp Eye Res; 2006 Dec; 83(6):1335-9. PubMed ID: 16965772
[TBL] [Abstract][Full Text] [Related]
26. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells.
Miyata N; Gon Y; Nunomura S; Endo D; Yamashita K; Matsumoto K; Hashimoto S; Ra C
Int Immunopharmacol; 2008 Jun; 8(6):874-80. PubMed ID: 18442792
[TBL] [Abstract][Full Text] [Related]
28. Binding properties of IgE receptors on normal mouse mast cells.
Sterk AR; Ishizaka T
J Immunol; 1982 Feb; 128(2):838-43. PubMed ID: 7054296
[TBL] [Abstract][Full Text] [Related]
29. Functional and partial chemical characterization of the carbohydrate moieties of the IgE receptor on rat basophilic leukemia cells and rat mast cells.
Pecoud AR; Ruddy S; Conrad DH
J Immunol; 1981 Apr; 126(4):1624-9. PubMed ID: 7204980
[TBL] [Abstract][Full Text] [Related]
30. A new FcεRI receptor-mimetic peptide (PepE) that blocks IgE binding to its high affinity receptor and prevents mediator release from RBL 2H3 cells.
Sandomenico A; Monti SM; Palumbo R; Ruvo M
J Pept Sci; 2011 Sep; 17(9):604-9. PubMed ID: 21538708
[TBL] [Abstract][Full Text] [Related]
31. Role of the extracellular domain of Fc epsilon RI alpha in intracellular processing and surface expression of the high affinity receptor for IgE Fc epsilon RI.
Hartman ML; Lin SY; Jouvin MH; Kinet JP
Mol Immunol; 2008 Apr; 45(8):2307-11. PubMed ID: 18179824
[TBL] [Abstract][Full Text] [Related]
32. Intracellular delivery of bioactive peptides to RBL-2H3 cells induces beta-hexosaminidase secretion and phospholipase D activation.
Howl J; Jones S; Farquhar M
Chembiochem; 2003 Dec; 4(12):1312-6. PubMed ID: 14661273
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of IgE-mediated phosphorylation of FcepsilonRIgamma protein by antiallergic drugs in rat basophilic leukemia (RBL-2H3) cells: a novel action of antiallergic drugs.
Hanashiro K; Sunagawa M; Nakasone T; Nakamura M; Kosugi T
Int Immunopharmacol; 2007 Jul; 7(7):994-1002. PubMed ID: 17499203
[TBL] [Abstract][Full Text] [Related]
34. Convergent recognition of the IgE binding site on the high-affinity IgE receptor.
Stamos J; Eigenbrot C; Nakamura GR; Reynolds ME; Yin J; Lowman HB; Fairbrother WJ; Starovasnik MA
Structure; 2004 Jul; 12(7):1289-301. PubMed ID: 15242605
[TBL] [Abstract][Full Text] [Related]
35. Insights into immunoglobulin E receptor signaling from structurally defined ligands.
Holowka D; Sil D; Torigoe C; Baird B
Immunol Rev; 2007 Jun; 217():269-79. PubMed ID: 17498065
[TBL] [Abstract][Full Text] [Related]
36. Compartmentalization of the Type I Fc epsilon receptor and MAFA on mast cell membranes.
Barisas BG; Smith SM; Liu J; Song J; Hagen GM; Pecht I; Roess DA
Biophys Chem; 2007 Mar; 126(1-3):209-17. PubMed ID: 16797115
[TBL] [Abstract][Full Text] [Related]
37. IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site.
Sandomenico A; Monti SM; Marasco D; Dathan N; Palumbo R; Saviano M; Ruvo M
Mol Immunol; 2009 Oct; 46(16):3300-9. PubMed ID: 19699527
[TBL] [Abstract][Full Text] [Related]
38. Binding characteristics of aggregated IgGa to rat basophilic leukaemia (RBL) cells and rat mast cells.
Möller G; König W
Immunology; 1980 Nov; 41(3):605-15. PubMed ID: 7461703
[TBL] [Abstract][Full Text] [Related]
39. In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells.
Naal RM; Tabb J; Holowka D; Baird B
Biosens Bioelectron; 2004 Nov; 20(4):791-6. PubMed ID: 15522594
[TBL] [Abstract][Full Text] [Related]
40. Roles of the transmembrane domain and the cytoplasmic domain of Fc epsilon RI alpha in immunoglobulin E-mediated up-regulation of surface Fc epsilon RI expression.
Okayama Y; Kagaya S; Yuki K; Arai T; Saito H
Clin Exp Allergy; 2007 Mar; 37(3):451-8. PubMed ID: 17359395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
